Gossan Resources Limited
GSR.F
0.01 EUR
1 day: +10.0% (0.00 EUR)
The alert is saved directly without jumping back to the homepage.
Price alerts for GSR.F
Please log in to view and save price alerts.
Finanzen
Company info
Gossan Resources Limited, an exploration and evaluation stage company, engages in the acquisition, exploration, and development of resource properties in Canada. It holds interest in the Glitter property covering an area of 4500 hectares located in the Sturgeon Lake Greenstone Belt of Northwestern Ontario; the Gander Gold property covers an area of 9050 hectares situated in Newfoundland; and the Weir Pond project covers an area of 975 hectares and the Island Pond properties cover an area of 1,050 hectares located in Newfoundland. The company also owns interests in a portfolio of properties hosting gold and base metals, as well as specialty green battery metals, vanadium, titanium, tantalum, lithium, dolomite, and chromium. In addition, it holds production royalty interests in a high-purity silica sand deposit. Gossan Resources Limited was incorporated in 1980 and is headquartered in Winnipeg, Canada.
Aktuelle News
-
Cytotoxic Drugs Market Report Now Available — Forecasts Market Growth from $16.21B (2026) to $21.06B by 2031, Profiling Pfizer, Roche, Novartis, AstraZeneca, Sanofi, and 15 Other Key Players
Vorschau anzeigen
Earlier cancer detection, wider reimbursement and emerging-market access boost demand, while oral therapies, antimetabolites, ADCs, telehealth and online pharmacies create opportunities.Dublin, Aug. 28, 2026 (GLOBE NEWSWIRE) -- The "Cytotoxic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. Cytotoxic Drugs Market to Reach USD 21.06 Billion by 2031 as Cancer Treatment Demand Expands The global cytotoxic
-
Rocket Factory Augsburg Signs ESA Contract Under the European Launcher Challenge
Vorschau anzeigen
AUGSBURG and BREMEN, GERMANY - August 27, 2026 (NEWMEDIAWIRE) - Rocket Factory Augsburg (RFA) signed a contract with the European Space Agency (ESA) under the European Launcher Challenge (ELC). The agreement makes RFA one of the selected European...
-
Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves
Vorschau anzeigen
Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.
-
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
Vorschau anzeigen
FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.
-
Atrial Fibrillation Market Trends and Forecast 2026-2035 Featuring Profiles of Abbott, Boston Scientific, Medtronic, Johnson & Johnson, Novartis, and Sanofi
Vorschau anzeigen
Antiarrhythmic agents account for around 55% of the therapy landscape, while monoclonal antibodies are emerging as an investigational approach Atrial Fibrillation Market Atrial Fibrillation Market Dublin, Aug. 26, 2026 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation Market by Treatment, Type of Drug, Type of Drug Molecule, Type of Target, Route of Administration, Type of Device, Type of Technology, End User, Geographical Regions and Sales Forecast - Trends and Forecast Till 2035" has been added to